PDF Archive

Easily share your PDF documents with your contacts, on the Web and Social Networks.

Share a file Manage my documents Convert Recover PDF Search Help Contact



ER1107 .pdf


Original filename: ER1107.pdf

This PDF 1.7 document has been generated by Microsoft® Word 2016, and has been sent on pdf-archive.com on 11/09/2018 at 12:11, from IP address 92.253.x.x. The current document download page has been viewed 204 times.
File size: 91 KB (1 page).
Privacy: public file




Download original PDF file









Document preview


Monday, 12 June

Tuesday

Breast Cancer

Lung Cancer

08:00 • 10:00: Registration

10:00 - 11:00 Immediate
breast reconstruction after
mastectomy with
implants: Prof. Dr.
Alexandru Blidaru
11:00 - 11:30: Break

09:30 - 10:15 Surgery vs
radiation therapy in stage
I NSCLC. Surgery: Prof.
Dr. AJireza Hoda
10:15 - 11:00 Surgery vs
radiation therapy in stage
I NSCLC. Radiation
therapy: Prof. Dr. Van
Houtte Paul
11:00 - 11:30: Break
11.30-12.15 NSCLC
early stage: Adjuvant vs
neoadjuvant
chemotherapy: Dr.
Mircea Dediu

11:30 - 12:30 Overcoming
treatment resistance in
breast cancer: Prof. Dr.
Christoph Zielinsky

12 30 - 13:30: Lunch

12.15- 13 00 SCLC:
Current status and further
perspectives: Prof. Dr.
Lucian Miron

13:00 - 14 00: Lunch

13:30 - 14:15 Should
axillary dissection be
performed in sentinel
positive BC? Speaker in
favor surgery: Prof Dr
Maria Joao Cardoso

14:00 - 15:00 Immune
therapy in NSCLC: Prof.
Dr. Tudor Ciuleanu

14:15 - 15:00 Should
axillary dissection be
performed in sentinel
positive BC? Speaker in
favor radiotherapy: Dr. Ivica
Ratosa

15:00 - 15:40 Making the
first decision in EGFRM
+ NSCLC in advanced
setting: Prof. Dr. Tudor
Ciuleanu & Dr Mircea
Dediu

15:00- 15:45 Should 10
years adjuvant endocrine
treatment be the standard
of care? Dr Alexandru
Eniu

15:40 — 16:40 Targeted
therapy in oncogene
driven NSCLC: Dr. Mircea
Dediu

15:45 - 16:15: Break
16:15 - 18:00 Tumor board
breast cancer

16:40 - 17:00: Break
17.00 Tumor board lung
cancer

Wednesday
Immunology
Melanoma and
sarcoma

Thursday
Colorectal
Interesting cases from
audience

09:30 - 10:30 Basics of
Immunology: Dr Martin
Holcmann

09:30 - 10.30 Invasive vs
non-invasive treatment for
liver metastases.
Invasive: Prof. Dr. Irinel
Popescu

09:30 - 11:00 RCC first
line: how to choose the
adequate treatment. RCC
second line: A crowded
avenue: which way to go?
Assoc. Prof. Martin Pichler

10:30 - 11:00: Break

11 00 - 11:30 Break

11:00 - 12:00 Invasive vs
non-invasive treatment for
liver metastases. Noninvasive: Prof. Dr Sharma
Ricky

11:30-12:15 Bladder
cancer: current status of
systemic treatment in
advanced and metastatic
stage: Assoc. Prof. Dr.
Laurentia Gales

10:30 - 11 00 Break

11:00 - 12:00 Malignant
melanoma. Adjuvant IO:
Conf. Dr. Serban Negru

12:00-13:00
Metastatic debate TT vs
IO: Dr. Martin Holcmann

13:00- 14 00: Lunch

12:00 -13:00
Antiangiogenic vs anti
EGFR monoclonal Ab in
RAS wild type colon
cancer: which first? Prof.
Dr. Gerald Prager

14:00- 15:00 Skin
toxicity management:
Prof. Dr. Janja Ocvirk

15:00 - 16:00 Sarcoma
Radiotherapy: Prof. Dr.
Rodica Anghel

15:00 - 16:30 Interesting
cases from audience

16.30 Tumor board
melanoma and sarcoma

RCC, Bladder, Prostate

12:15-13:00 Bladder
cancer radiotherapy: Conf.
Dr. Laura Rebegea
13:00 - 13:45 Prostate
cancer: how to choose
among the new endocrine
options? Assoc. Prof. Dr.
Gabriel Kacso

13:00 - 14 00: Lunch

14:00 - 15:00 Sarcoma
Systemic treatment:
Prof. Dr. Thomas
Brodowicz

16:00 - 16 30 Break

Friday

Diploma release

16:30 - 16:45: Break
16:45 Interesting cases
from audience


Document preview ER1107.pdf - page 1/1

Related documents


er1107
untitled pdf document
minesh p mehta cv
esmo preceptorship on lung cancer manchester 2020 programmeocr
1 s2 0 s0936655504002225 main
bone cancer treatment


Related keywords